BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Clinical Outcome
6 results:

  • 1. Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome.
    Marazzi F; Masiello V; Marchesano D; Boldrini L; Luzi S; Ferrara PE; Amabile E; Piccari D; Landi F; Moschella F; Franceschini G; Masetti R; Mantini G; Valentini V; Smaniotto D
    Tumori; 2019 Aug; 105(4):319-330. PubMed ID: 30935295
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients.
    Binkhorst L; Kloth JSL; de Wit AS; de Bruijn P; Lam MH; Chaves I; Burger H; van Alphen RJ; Hamberg P; van Schaik RHN; Jager A; Koch BCP; Wiemer EAC; van Gelder T; van der Horst GTJ; Mathijssen RHJ
    Breast Cancer Res Treat; 2015 Jul; 152(1):119-128. PubMed ID: 26050156
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. 3'-Deoxy-3'-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patients.
    Idema AJ; Hoffmann AL; Boogaarts HD; Troost EG; Wesseling P; Heerschap A; van der Graaf WT; Grotenhuis JA; Oyen WJ
    J Nucl Med; 2012 Dec; 53(12):1904-10. PubMed ID: 23077112
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response.
    Arslan C; Aksoy S; Dizdar O; Kurt M; Güler N; Ozisik Y; Güllü I; Altundag K
    Tumori; 2011; 97(6):711-6. PubMed ID: 22322836
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients.
    Aubele M; Auer G; Braselmann H; Nährig J; Zitzelsberger H; Quintanilla-Martinez L; Smida J; Walch A; Höfler H; Werner M
    Anal Cell Pathol; 2002; 24(2-3):77-87. PubMed ID: 12446957
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Heterogeneity of intratumour proliferative activity in primary breast cancer: biological and clinical aspects.
    Paradiso A; Mangia A; Barletta A; Fusilli S; Marzullo F; Schittulli F; De Lena M
    Eur J Cancer; 1995 Jun; 31A(6):911-6. PubMed ID: 7646920
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.